| 69.83 0.41 (0.59%) | 10-28 16:00 | |||||||||||||
|
|
| Short term |   |
|||
| Mid term |  |
|||
| Targets | 6-month : | 82.55 | 1-year : | 96.42 |
| Resists | First : | 70.68 | Second : | 82.55 |
| Pivot price | 66.84 |
|||
| Supports | First : | 65.37 | Second : | 62.09 |
| MAs | MA(5) : | 70 |
MA(20) : | 66.04 |
| MA(100) : | 68.23 |
MA(250) : | 73.07  |
|
| MACD | MACD : | 0.9 |
Signal : | 0.2 |
| %K %D | K(14,3) : | 89.1 |
D(3) : | 91.5 |
| RSI | RSI(14): 62.7 |
|||
| 52-week | High : | 87.21 | Low : | 61.83 |
Price has closed below its short-term moving average. Short-term moving average is currently above mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and NEUTRAL in mid-long term.[ ALC ] has closed below upper band by 21.7%. Bollinger Bands are 82.7% wider than normal. The large width of the bands suggest high volatility as compared to its normal range. The bands have been in this wide range for 4 days. This is a sign that the current trend might continue.
| If tomorrow: | Open lower | Open higher |
| High: | 70.11 - 70.54 | 70.54 - 70.94 |
| Low: | 67.84 - 68.34 | 68.34 - 68.82 |
| Close: | 69.06 - 69.8 | 69.8 - 70.51 |
Alcon Inc. researches, develops, manufactures, distributes, and sells eye care products worldwide. The company operates through two segments, Surgical and Vision Care. It offers equipment, instrumentation and diagnostics, intraocular lenses (IOLs), and other implantables; and consumables, including viscoelastics, surgical solutions, incisional instruments, surgical custom packs, and other products for surgical procedures. The company’s cataract products include Unity CS, LenSx laser system, Verion reference unit and Verion digital marker, ARGOS biometer, SMARTCATARACT health platform, NGENUITY 3D visualization system, LuxOR surgical ophthalmic microscope, and ORA system for intra-operative measurements; ADI cloud-based platform; and implantable products, including monofocal, Toric, and Presbyopia-Correcting IOLs, as well as delivery systems, such as AutonoMe and UltraSert. In addition, it provides Custom Pak surgical procedure packs vitreoretinal products comprising constellation vision systems, procedure packs, lasers and hand-held microsurgical instruments, Grieshaber, MIVS instruments; scissors, forceps and micro-instruments, medical grade vitreous tamponades, and Hypervit probes; and refractive surgery products, including WaveLight and Contoura Vision used for LASIK refractive procedure. Further, the company offers daily disposable, reusable, and color-enhancing contact lenses; ocular health products, such as dry eye, ocular allergies, glaucoma, and contact lens care, as well as ocular vitamins and redness relievers. The company was formerly known as Alcon Universal S.A. and changed its name to Alcon Inc. in December 2001. Alcon Inc. was founded in 1945 and is headquartered in Geneva, Switzerland.
Mon, 26 Oct 2026
Alcon: Keeping An Eye Out Here Amid Sales And Margin Momentum (NYSE:ALC) - Seeking Alpha
Thu, 22 Oct 2026
Alcon Inc (ALC) Shares Surge 4.8% -- What GF Score of 74 Tells I - GuruFocus
Wed, 21 Oct 2026
Alcon Sees Another Bullish Rating After Clear Portfolio Growth Direction In Eyecare (ALC) - Seeking Alpha
Fri, 04 Sep 2026
Is it a Prudent Move to Retain ALC Stock in Your Portfolio Now? - Yahoo Finance
Thu, 03 Sep 2026
Alcon Stock: A Re-Rating In Eyesight (NYSE:ALC) - Seeking Alpha
Wed, 19 Aug 2026
What Makes Alcon (ALC) a Bullish Bet? - Yahoo Finance
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Outperform |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Underperform |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Outperform |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Neutral |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Underperform |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Underperform |
|
Exchange:
NYSE
|
|
|
Sector:
Healthcare
|
|
|
Industry:
Medical - Specialties
|
|
| Shares Out | 483 (M) |
| Shares Float | 482 (M) |
| Held by Insiders | 0.2 (%) |
| Held by Institutions | 63 (%) |
| Shares Short | 17,880 (K) |
| Shares Short P.Month | 14,570 (K) |
| EPS | 1.32 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 44.66 |
| Profit Margin | 5.9 % |
| Operating Margin | 14.6 % |
| Return on Assets (ttm) | 2.7 % |
| Return on Equity (ttm) | 2.9 % |
| Qtrly Rev. Growth | 8.6 % |
| Gross Profit (p.s.) | 12.86 |
| Sales Per Share | 22.46 |
| EBITDA (p.s.) | 4.96 |
| Qtrly Earnings Growth | 0 % |
| Operating Cash Flow | 2,310 (M) |
| Levered Free Cash Flow | 1,270 (M) |
| PE Ratio | 52.9 |
| PEG Ratio | 1.2 |
| Price to Book value | 1.56 |
| Price to Sales | 3.1 |
| Price to Cash Flow | 14.61 |
| Dividend | 0.36 |
| Forward Dividend | 0 |
| Dividend Yield | 0.5% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|